search icon
Join IDSAJOIN IDSA >> Go to MyIDSAGO TO MYIDSA >>
  • What's New in Practice Management & Payment

    Now Available: MIPS Performance Feedback, Final Score, and Targeted Review

    MIPS Reporting Deadlines Fast Approaching: 10 Things to Do and Know

    CMS MIPS Data Submission Portal Now Available

    2016 Physician Compare Data Now Available

    AMA Releases an Interactive Web-based Tool for MIPS

  • 2018 ID Week logo final
  • News from IDSA and Journals

    8/14/2018

    Societies Recommend Policies to Retain, Increase Ranks of Infectious Diseases Physician Scientists

    Read More >>

    Improved compensation, expanded mentorship and training opportunities, and concrete measures to improve workforce diversity are all needed to address attrition from the ranks of physician scientists specializing in infectious diseases...

  • CDC and FDA Alerts

    8/17/2018 2:00:03 PM

    To Protect Patients, Follow Clinical Guidelines When Prescribing Fluoroquinolones

    Appropriate fluoroquinolone prescribing is important for patient safety.

    8/9/2018 3:32:30 PM

    Response to new Ebola outbreak in North Kivu/Democratic Republic of the Congo

    CDC has been responding and coordinating with the Ministry of Health of the Democratic Republic of the Congo (DRC) since a new outbreak of Ebola in North Kivu province was reported on July 30, 2018.

    8/9/2018 3:31:41 PM

    CDC: Update on Ebola Virus Disease Outbreak in Democratic Republic of Congo

    On May 8, 2018, the Ministry of Public Health (MoHP) of Democratic Republic of the Congo (DRC) declared an outbreak of Ebola virus disease (EVD) in Bikoro Health Zone, Equateur Province, in Northwest DRC.

    5/14/2018 4:14:45 PM

    Auromedics Pharma LLC Issues Voluntary Nationwide Recall

    AuroMedics Pharma LLC is voluntarily recalling two lots of Piperacillin and Tazobactam for injection, USP 3.375 g (Piperacillin Sodium equivalent to 3 g of Piperacillin USP and Tazobactam Sodium equivalent to 0.375 g of Tazobactam USP. Each vial contains 7.05 mEq (162 mg) of Sodium) in a Single-Dose vial, to the hospital level.

    4/26/2018 2:46:41 PM

    Lamictal (lamotrigine): Drug Safety Communication - Serious Immune System Reaction

    The FDA is warning that the medicine Lamictal (lamotrigine) for seizures and bipolar disorder can cause a rare but very serious reaction that excessively activates the body’s infection-fighting immune system.

    3/6/2018 2:47:49 PM

    Updated Influenza and Hep A Vaccine Resolutions

    In February 2018, ACIP updated influenza vaccine and hepatitis A vaccine resolutions for the Vaccines for Children Program. The changes are:

    2/20/2018 2:47:27 PM

    Multistate Outbreak of Salmonella

    CDC, public health and regulatory officials in several states, and the U.S. Food and Drug Administration (FDA) are investigating a multistate outbreak of Salmonella I 4,[5],12:b:- infections.

    1/19/2018 11:25:10 AM

    Levofloxacin in 5 Percent Dextrose 250mg/50mL by AuroMedics: Recall - Presence of Visible Particulate Matter

    AuroMedics Pharma LLC is voluntarily recalling one lot of Levofloxacin in 5% Dextrose Injection 250mg/50mL in a Single-Use flexible container NDC 55150-243-46, Lot CLF160003, Expiry date May 2018, to the hospital level.

| HIVMA | Contact Us

© Copyright IDSA 2018 Infectious Diseases Society of America

Full Site Mobile Site